Rafael holdings reports second quarter fiscal 2022 financial results

Newark, n.j., march 17, 2022 (globe newswire) -- rafael holdings, inc. (nyse: rfl), an early-stage novel cancer and immune metabolism therapeutics company, today reported its financial results for the three and six months ended january 31, 2022. the end of our second fiscal quarter marks a beginning for the reorganized and focused rafael holdings with bill conkling assuming the responsibilities of chief executive officer from ameet mallik as of february 1, 2022. the company is focused on accelerating the development of our novel cancer and immune metabolism pipeline and exploring external opportunities to enhance the value of our company.
RFL Ratings Summary
RFL Quant Ranking